Nathalie M. Vandevelde
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Frequency of Participation in External Quality Assessment Programs Focused on Rare Diseases: Belgian Guidelines for Human Genetics Centers.
Journal: JMIR medical informatics
Published: March 09, 2021
Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions.
Journal: Orphanet journal of rare diseases
Published: June 12, 2020
The Use of Aspirin to Reduce the Risk of Thrombotic Events in Patients With End-Stage Renal Disease: Protocol for a Randomized Controlled Trial.
Journal: JMIR research protocols
Published: March 28, 2018
A pragmatic bottom-up approach to harmonize the units of clinical chemistry tests among Belgian clinical laboratories, focusing on immunoassays.
Journal: Clinical chemistry and laboratory medicine
Published: October 03, 2017
Modulating antibiotic activity towards respiratory bacterial pathogens by co-medications: a multi-target approach.
Journal: Drug discovery today
Published: February 08, 2016
Modulation of the activity of moxifloxacin and solithromycin in an in vitro pharmacodynamic model of Streptococcus pneumoniae naive and induced biofilms.
Journal: The Journal of antimicrobial chemotherapy
Published: December 29, 2014
Characterisation of a collection of Streptococcus pneumoniae isolates from patients suffering from acute exacerbations of chronic bronchitis: in vitro susceptibility to antibiotics and biofilm formation in relation to antibiotic efflux and serotypes/serogroups.
Journal: International journal of antimicrobial agents
Published: March 10, 2014
Antibiotic activity against naive and induced Streptococcus pneumoniae biofilms in an in vitro pharmacodynamic model.
Journal: Antimicrobial agents and chemotherapy
Published: December 18, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026